Latest press releases from the category Research / Development
|
Lophius Biosciences GmbH Joins NEU² and Receives Substantial Grant Funding for the Diagnosis and Monitoring of Multiple Sclerosis
, Research / Development, Lophius Biosciences GmbH
Bionamics GmbH, the coordinator of the NEU² consortium,and Lophius Biosciences GmbH announced today that Lophius Biosciences has joined the NEU² program with a project...
|
Quantum optics techniques support experiments in biology and medicine
, Research / Development, Gottfried Wilhelm Leibniz Universität Hannover
Optical imaging has long been the driver for some of the most sensitive measurements. Quantum optics has made excellent progress in exploring the limits and creating...
|
Masdar PV and Helmholtz-Zentrum Berlin partner to accelerate development of next generation thin film crystalline silicon PV technology
, Research / Development, Masdar PV GmbH
. - HZB's first milestone achieved by succeeding in depositing a thin, crystalline 10μm layer of silicon on glass utilizing laser-crystallization - Demonstration...
|
PatcH2O(TM) - Immediate and sustained hydration of skin
, Research / Development, BASF SE Kommunikation BASF-Gruppe
The secret of a beautiful, luminous and supple skin lies in its hydration. Dry, dehydrated skin is a very common problem in modern life, affecting people of all...
|
The Zwick Science Award - promoting science
, Research / Development, Zwick GmbH & Co. KG
On 17th April 2013 the winners of the the Zwick Science Award 2012 received their awards during the fourth Zwick Academia Day, held this year at Manchester University,...
|
Any Assay, Any Wavelength, Any Bandwidth with the New CLARIOstar® High Performance Microplate Reader
, Research / Development, BMG LABTECH GmbH
Over the years, many different assays have been designed to work on many different microplate readers. As new techniques emerged, so did new microplate reader technology....
|
UCB to collaborate with CRELUX and 4SC Discovery to meet unmet needs in neurology
, Research / Development, 4SC AG
4SC AG (Frankfurt, Prime Standard: VSC), a discovery and development company of targeted small molecule drugs mainly focusing on autoimmune diseases and cancer,...
|
Robotics and Automation - a vision of future technology
, Research / Development, Europäische Laborroboter Interessen Gemeinschaft Deutschland e.V.
ELRIG (European Laboratory Robotics Interest Group), invites researchers in the field of Robotics and Automation to attend its free conference and networking event...
|
QIAGEN comments on decision by a U.S. reference laboratory customer to consolidate purchase of women's health tests with competitor supplier
, Research / Development, QIAGEN GmbH
QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced that a U.S. reference laboratory customer of its HPV-related products used for cervical...
|
Lightest Exoplanet Imaged So Far?
, Research / Development, ESO - European Organisation for Astronomical Research in the Southern Hemisphere
A team of astronomers using ESO's Very Large Telescope has imaged a faint object moving near a bright star. With an estimated mass of four to five times that of...
|
ESI's sixth Vibro-Acoustic User Conference will take place June 5-6 in Paris, France
, Research / Development, ESI Engineering System International GmbH
ESI Group, pioneer and world-leading solution provider in Virtual Prototyping for manufacturing industries, announces the agenda of its sixth Vibro-Acoustic User...
|
|
QIAGEN expands pipeline of promising new biomarkers for development of Personalized Healthcare companion diagnostics
, Research / Development, QIAGEN GmbH
. - FGFR-TACC fusion genes, the target of potential targeted therapies for glioblastoma and other cancers, rights acquired from Columbia University - Several lymphoma-related...
|
White Sky iHouse unveiled
, Research / Development, White Sky Group
Tobias Lindemann, Architect and White Sky Group CEO, presented first design schemes of the White Sky iHouse in Dubai and Riyadh. The White Sky iHouse intends to...
|
|
4SC gives update on the clinical development of its lead cancer compound resminostat
, Research / Development, 4SC AG
. - Data from completed Phase I part of SHORE study in advanced colorectal cancer (CRC) to be presented at upcoming ASCO conference in Chicago, confirming the safety...
|
DYNAmore is involved in numerous research and development projects
, Research / Development, DYNAmore GmbH
DYNAmore GmbH is a medium-sized company for FEM engineering services. Due to the company's affinity to develop fundamentally-orientated methods in simulation technology,...
|
Earth Monitoring Competition: Copernicus Masters to Award EUR 350,000 in Prizes and Satellite Data
, Research / Development, Anwendungszentrum GmbH Oberpaffenhofen
The European Earth Monitoring Competition Copernicus Masters is rewarding ideas and innovative solutions benefitting business and society based on Earth observation...
|
World Scientific Congratulates Author on National Academy of Engineering Election
, Research / Development, World Scientific Publishing Co. Pte. Ltd.
World Scientific author Professor Dawn A. Bonnell has been elected as a member of the National Academy of Engineering. Professor Bonnell was cited for the development...
|
AB SCIEX Improves Food Safety with New Method to Identify Markers for Horse Meat and the Banned Veterinary Drug Residue Phenylbutazone
, Research / Development, AB SCIEX Germany GmbH
AB SCIEX, a global leader in analytical technology, today announced that its scientists have developed a new method for detecting horse tissue present in meat samples....
|
Imec and GLOBALFOUNDRIES collaborate to advance high-density memory technology
, Research / Development, imec
Imec and GLOBALFOUNDRIES announced today that they have expanded joint development efforts to advance STT-MRAM (spin-transfer torque magnetoresistive random access...
|
|
4SC's partner Yakult Honsha starts clinical Phase I/II study with cancer compound resminostat in liver cancer (HCC) in Japan
, Research / Development, 4SC AG
. - Phase I/II study to investigate safety and efficacy of resminostat/sorafenib combination vs. sorafenib alone as first-line treatment of advanced liver cancer...
Subscribe to this topic:
